These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 12758243

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. High-dose-rate brachytherapy for vaginal cancer: learning from treatment complications.
    Tyree WC, Cardenes H, Randall M, Papiez L.
    Int J Gynecol Cancer; 2002; 12(1):27-31. PubMed ID: 11860533
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
    Ning S, Trisler K, Wessels BW, Knox SJ.
    Cancer; 1997 Dec 15; 80(12 Suppl):2519-28. PubMed ID: 9406705
    [Abstract] [Full Text] [Related]

  • 28. High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme.
    Wang CJ, Leung SW, Chen HC, Sun LM, Fang FM, Changchien CC, Huang EY, Wu JM, Chen CC.
    Int J Radiat Oncol Biol Phys; 1997 May 01; 38(2):391-8. PubMed ID: 9226328
    [Abstract] [Full Text] [Related]

  • 29. The adverse effect of treatment prolongation in cervical cancer by high-dose-rate intracavitary brachytherapy.
    Chen SW, Liang JA, Yang SN, Ko HL, Lin FJ.
    Radiother Oncol; 2003 Apr 01; 67(1):69-76. PubMed ID: 12758242
    [Abstract] [Full Text] [Related]

  • 30. High dose rate intracavitary brachytherapy for recurrent or residual lesions in the vaginal cuff: results in post-hysterectomy patients with carcinoma of the cervix.
    Ogino I, Kitamura T, Okamoto N, Nakayama H, Matsubara S.
    Int J Gynecol Cancer; 2001 Apr 01; 11(1):61-8. PubMed ID: 11285035
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Carcinoma of the uterine cervix. II. Lack of impact of prolongation of overall treatment time on morbidity of radiation therapy.
    Perez CA, Grigsby PW, Castro-Vita H, Lockett MA.
    Int J Radiat Oncol Biol Phys; 1996 Jan 01; 34(1):3-11. PubMed ID: 12118562
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy.
    Kapp KS, Stuecklschweiger GF, Kapp DS, Poschauko J, Pickel H, Lahousen M, Hackl A.
    Int J Radiat Oncol Biol Phys; 1998 Oct 01; 42(3):531-40. PubMed ID: 9806511
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study.
    Eifel PJ, Moughan J, Owen J, Katz A, Mahon I, Hanks GE.
    Int J Radiat Oncol Biol Phys; 1999 Jan 15; 43(2):351-8. PubMed ID: 10030261
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.